Key result
Hybrid open TMVR for severe MAC demonstrates ~83% one-year survival.
Why the study?
Mitral stenosis with extensive mitral annular calcification remains surgically challenging with risks including prolonged surgery time, ventricular rupture, and systolic anterior motion.
Does an open hybrid implantation of a transcatheter prosthesis improve survival and procedural outcomes in patients with severe mitral valve stenosis and extensive annular calcification?
Observational (n=6)
No
Does an open hybrid implantation of a transcatheter prosthesis improve survival and procedural outcomes in patients with severe mitral valve stenosis and extensive annular calcification?
Open hybrid implantation of a transcatheter balloon-expandable valve is a feasible bail-out strategy for high-risk patients with severe mitral stenosis and extensive annular calcification, yielding an 83.3% 1-year survival rate.
Answers are grounded in this paper and cite their sources.
Supports hybrid TMVR feasibility in severe MAC; leaves open need for prospective trials before wider adoption.
Background and Objectives: Mitral stenosis with extensive mitral annular calcification (MAC) remains surgically challenging in respect to clinical outcome. Prolonged surgery time with imminent ventricular rupture and systolic anterior motion can be considered as a complex of causal factors. The aim of our alternative hybrid approach was to reduce the risk of annual rupture and paravalvular leaks and to avoid obstruction of the outflow tract. A review of the current literature was also carried out. Materials and Methods: Six female patients (mean age 76 ± 9 years) with severe mitral valve stenosis and severely calcified annulus underwent an open implantation of an Edwards Sapien 3 prosthesis on cardiopulmonary bypass. Our hybrid approach involved resection of the anterior mitral leaflet, placement of anchor sutures and the deployment of a balloon expanded prosthesis under visual control. Concomitant procedures were carried out in three patients. Results: The mean duration of cross-clamping was 95 ± 31 min and cardiopulmonary bypass was 137 ± 60 min. The perioperative TEE showed in three patients an inconspicuous, heart valve-typical gradient on all implanted prostheses and a clinically irrelevant paravalvular leakage occurred in the anterior annulus. In the left ventricular outflow tract, mild to moderately elevated gradients were recorded. No adverse cerebrovascular events and pacemaker implantations were observed. All but one patient survived to discharge. Survival at one year was 83.3%. Conclusions: This “off label” implantation of the Edwards Sapien 3 prosthesis may be considered as a suitable bail-out approach for patients at high-risk for mitral valve surgery or deemed inoperable due to extensive MAC.
No takes yet. Share an insight, caveat, or question.
Bagaev et al. (2022) conducted an observational in Severe mitral valve stenosis with severe mitral annular calcification (n=6). Hybrid open transcatheter mitral valve replacement (Edwards Sapien 3) was evaluated on Survival at one year.
Synapse has enriched 10 related papers. Consider them for comparative context: